Ing Investment Management »

Candel Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $130k 13k 10.30
2025-06-30 $56k 11k 5.06

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Micron Technology (MU)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Lam Research Corp Com New (LRCX)
Caterpillar (CAT)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Applied Materials (AMAT)

View all positions for Ing Investment Management

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics